本文已被:浏览 57次 下载 25次
Received:August 08, 2025 Published Online:May 01, 2026
Received:August 08, 2025 Published Online:May 01, 2026
中文摘要: 溃疡性结肠炎(UC)的发病与肠道菌群失调密切相关,其中嗜黏蛋白阿克曼菌(Akkermansia muciniphila,Akk菌)的丰度 下降是重要特征。近年来研究发现,中草药活性成分可通过显著提升Akk菌丰度,调控短链脂肪酸水平、增强肠黏膜屏障、降 低炎症因子水平等,进而改善UC症状。本文系统综述了Akk菌在UC治疗中的作用以及中草药活性成分调控Akk菌改善UC 的机制,为开发基于肠道菌群干预的UC辅助疗法提供新的理论依据。
Abstract:The onset of ulcerative colitis(UC)is closely related to intestinal flora imbalance,with a significant decrease in the abundance of Akkermansia muciniphila being a key feature. Recent studies have found that active components of Chinese medicine can improve UC symptoms by significantly increasing the abundance of Akkermansia muciniphila,regulating short-chain fatty acid levels, enhancing the intestinal mucosal barrier,and reducing the levels of inflammatory factors. This article systematically reviews the role of Akkermansia muciniphila in the treatment of UC and the mechanism by which active components of Chinese medicine regulate Akkermansia muciniphila to improve UC,providing a new theoretical basis for the development of UC adjuvant therapies based on intestinal flora intervention.
keywords: Akkermansia muciniphila Ulcerative colitis Intestinal microecology Chinese medicine Active component Gut microflora Intestinal mucosal barrier
文章编号: 中图分类号:R574.62 文献标志码:A
基金项目:国家重大战略需求和地方经济社会发展专项(31920250079);临床医学肝病诊治中心(2021yxky079);甘肃省青年科技基金(23JRRA1675);
引用文本:
